Deschloro Dasatinib-d7
Deschloro Dasatinib-d7 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Dasatinib. The product is supplied by Clearsynth under CAT No. CS-T-103888. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Product Specifications
Overview
Deschloro Dasatinib-d7 is the labelled analogue of Deschloro Dasatinib (D289265), the impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product.
Synonyms
Deschloro Dasatinib-d7
Molecular Formula
C 22 H 20 D 7 N 7 O 2 S
Molecular Weight
460.6
Additionnal Information
Deschloro Dasatinib-d7 is supplied with detailed characterization data compliant with regulatory guideline. Deschloro Dasatinib-d7 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Dasatinib.
Storage Conditions
Refer MSDS for complete information.
Applications Notes
Deschloro Dasatinib-d7 is the labelled analogue of Deschloro Dasatinib (D289265), the impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product.
HSN Code
38229010
Hazard Compound
Refer MSDS for complete information.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
